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Background: Studies show the effectiveness of group psychoeducation in reducing symptoms in people with
depression. However, few controlled studies that have included aspects of personal care and healthy lifestyle
(diet, physical exercise, sleep) together with cognitive-behavioral techniques in psychoeducation are proven to be
effective.
The objective of this study is to assess the effectiveness of a psychoeducational program, which includes aspects of
personal care and healthy lifestyle, in patients with mild/moderate depression symptoms in Primary Care (PC).
Methods: In a randomized, controlled trial, 246 participants over 20 years old with ICD-10 major depression were
recruited through nurses/general practitioners at 12 urban Primary Care Centers (PCCs) in Barcelona. The
intervention group (IG) (n=119) received a group psychoeducational program (12 weekly, 1.5 h sessions led by two
nurses) and the control group (CG) (n=112) received usual care. Patients were assessed at baseline and at, 3, 6 and
9 months. The main outcome measures were the BDI, EQ-5D and remission based upon the BDI.
Results: 231 randomized patients were included, of whom 85 had mild depression and 146 moderate depression.
The analyses showed significant differences between groups in relation to remission of symptoms, especially in the
mild depression group with a high rate of 57% (p=0.009) at post-treatment and 65% (p=0.006) at 9 month follow
up, and only showed significant differences on the BDI at post-treatment (p=0.016; effect size Cohen’s d’=.51) and
at 6 and 9 month follow-up (p= 0.048; d’=.44).
In the overall and moderate sample, the analyses only showed significant differences between groups on the BDI at
post-treatment, p=0.02 (d’=.29) and p=0.010 (d’=.47), respectively.
The psychoeducation group improved significantly on the EQ-5D at short and long-term.
Conclusions: This psychoeducational intervention is a short and long-term effective treatment for patients with
mild depression symptoms. It results in a high remission rate, is recommended in PC and can be carried out by
nurses with previous training. In moderate patients, group psychoeducation is effective in the short-term.
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As depressive disorders are major public health pro-
blems with a prevalence of major depression in Europe
of 8.56% [1] and, strikingly, 5-16% in primary care
patients, they are the third leading cause of consult-
ation in primary health care [2-4].
The impact of depressive symptoms on quality of life
(QoL) has already been shown in a community popula-
tion [5]. The impact of depression on patients’ well-being
and QoL has been shown to be equal to or greater than
several other major chronic medical conditions such as
diabetes mellitus, heart disease and arthritis [6-8].
Depression has been associated with greater morbidity,
mortality, health care utilization and health care costs
[9,10]. The economic costs of depression have doubled
in the last ten years, mainly due to an increase in indir-
ect costs from loss of productivity [11].
There are a wide variety of psychological interventions
for treating depression [12] and one which has been
shown to be effective in treating depression is psychoe-
ducation [12,13]. A meta-analysis indicates that psychoe-
ducation has an effect size that is comparable with other
modalities of treatment for depression [14]. With regard
to the management of mild to moderate depression
symptoms, psychoeducation is an effective therapy in the
treatment of depression in adults [13,15] as it reduces
the depression symptoms and can prevent depression in
primary care patients [16-18].
Most international clinical practice guidelines (CPG)
for the management of depression recommend psycho-
educational interventions and brief psychotherapies as a
first step in the treatment protocol [15,19,20].
In this case, when we talk about psychoeducation,
we refer to group psychoeducation which is offered to
people with a mental disorder to help them understand
and manage their disease. This is done by reinforcing
patients’ resources and skills so that they are better able
to cope with their situation, prevent relapse and contrib-
ute to their own health and welfare. The educational inter-
vention was based on the patients’ active involvement in
the analysis of their situation and its solution. As such, it
includes psychotherapeutic techniques (behavioral activa-
tion, cognitive behavioral therapy and problem solving)
and homework tasks. At the group level, information is
provided to several patients about their condition and they
have the chance to exchange ideas about their experiences;
creating a space for mutual help group [21-23].
Psychoeducation has been used in health-care and
community settings and seems effective in prevention
and quality improvement programs in US primary care
[18,24,25]. In Europe, this psychoeducational interven-
tion has proved to be effective in reducing depression
symptoms in mild and moderate depression in the short
term [26,27] and long-term [28], and has shown it canbe carried out by community nurses with previous
training [24,27,29,30].
The majority of studies which have assessed the ef-
fectiveness of psychoeducation have used “Coping with
depression (CWD)” or a version of it. The CWD is a
cognitive, psychoeducative, behavioral intervention based
on the theory of depression and social learning (Teri &
Lewinsohn, 1986) [31] which aims to improve self-
esteem levels and social support, and develop/improve
those skills which have been found to help in the preven-
tion of depression from its onset: social skills, activity
level management (pleasurable activities) and manage-
ment of depressive thought.
There are other psychoeducational formats such as a
psyco-educational cognitive workshops [32], cognitive
bibliotherapy [33], education and group counselling [34],
and some psychoeducational interventions as well as
computerized cognitive behavioral therapy [35-37] and
psychoeducation through a website [38] which included
aspects of the healthy lifestyle recommended in their
program.
To date, there is evidence of the effectiveness of
psychoeducational intervention in the Primary Care
depressive population [26,27], although there are no
studies that have recorded important aspects of patients’
personal care (diet, physical activity, sleep hygiene, infor-
mation on the importance of therapeutic adherence and
the side-effects of pharmacological treatment) and the
identification and management of depression symptoms
within the psychoeducational group intervention; aspects
which have already been shown to aid recovery in these
patients [15,39]. This new psychoeducational group
intervention format is based on three fundamental care
aspects for the patient with depression: improving know-
ledge of the disorder, promoting a healthy life-style and
acquisition of habits which are beneficial to health, and
the development of resources to cope with critical situa-
tions (behavioral activation techniques, cognitive behav-
ioral therapy, problem-solving and breathing-relaxation).
The main objective of the study is to evaluate the
effectiveness of this intervention through the rate of
remission in the study sample post-intervention and at
6 and 9-month follow-up and, to determine whether the
improvement in depression symptoms is associated with
an improvement in quality of life at post-treatment and
at follow-up.
As secondary objectives, we were interested in analyzing
which population most benefits from this intervention; the
population with “mild” or “moderate” symptoms.
Methods
Randomized controlled trial, open parallel-group was
conducted between December, 2008, and April, 2010, in
primary care centers in Barcelona, Spain.
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A total of 246 participants were recruited by general
practitioners (GPs) and nurses between December, 2008,
and March, 2009, in 12 primary care centers (PCC) in
the Barcelona urban area. These PCC participants had
varying socio-demographic and economic resources.
Inclusion criteria were: a) patients older than 20 years
of both sexes; b) diagnosed with a major depressive dis-
order according to the International Classification of
Disease 10th revision (ICD-10) [40]; c) having mild to
moderate symptoms according to the Beck Depression
Inventory (BDI ≥10 and <30) and d) provision of signed
informed consent.
Exclusion criteria were: a) patients with other diag-
nosed associated psychiatric disorders (including person-
ality disorders and drug and alcohol abuse); b) current
presence of suicidal ideation or suicide attempts; c) using
secondary mental health services; d) patients with acute
or terminal medical illness; e) inability to speak and
understand Spanish and/or Catalan language; f ) sensory
or cognitive disabilities; g) illiteracy; h) temporary resi-
dents or i) non-provision of consent. Concurrent treat-
ment with antidepressants was not an exclusion criterion
but patients taking antidepressant medication could
not have changed their treatment during the previous
month.
Ethical approval was granted by the Jordi Gol i Gurina
Foundation. Informed consent was obtained from all
participants prior to their involvement in the study.
Procedure
Recruitment of participants
Nurses and GPs at each PCC were responsible for identi-
fying patients with a possible diagnosis of depression.
Once detected, the GPs were responsible for diagnosing
depression disorder according to the ICD-10. Partici-
pants who met BDI criteria for mild or moderate depres-
sion (a score of BDI ≥10 and <30) were provisionally
accepted into the trial.
The time of patient recruitment was 2 months prior to
the start of the intervention. If, after two months, the 24
patients were not recruited, the intervention began with
the available patients. Therefore, we prepared rando-
mized series from 16 to 24, depending on the number of
patients recruited.
At each PCC two nurses were responsible for carrying
out patient assessment through an individual interview.
These nurses were the same as those that would conduct
the intervention group.
First evaluation and randomization
Initial assessment included sociodemographic character-
istics (age, gender, nationality, marital status, educational
level, number of children, employment status, economicstatus, core coexistence), medication (antidepressant,
anxiolytics, hypnotics), administration of the Beck Depres-
sion Inventory scale (BDI) and the EuroQol- 5D (EQ-5D)
questionnaire. All study variables were entered in a study
database.
All patients evaluated who met the inclusion criteria
were assigned a number consecutively. The participants
were randomly allocated to one of two conditions by
means of a computer-generated random allocation list.
The computer program carried out series randomized
from # 1 to 16, 18, 20, 22 and 24#, depending on the
number of participants in each PCC. For the interven-
tion group and control group the same number of
patients was used (minimum 16 people and maximum
24 per PCC).
An independent person was responsible for managing
the randomization lists. Subsequently, this individual
sent the randomization lists in a sealed envelope to the
two nurses at each PCC a few days before the interven-
tion began.
Follow up evaluations
All outcome variables were assessed four times: prior to
start of the study (pretest), after 3 months (post-test),
and at 6 and 9 months after inclusion (first and second
follow-up, respectively) in individual data collection
sessions.
Measures
Diagnoses for participants were based on the Inter-
national Classification of Diseases, 10th revision (ICD-10)
[40]. The diagnosis was made by the general practitioner.
Prior to the use of questionnaires, permission was
requested from the authors.
Beck depression inventory
The Beck Depression Inventory [41,42] is a brief scale
of 21 items which assesses the severity of depression
symptoms during the previous week. We selected the
BDI due to its good internal consistency, validity, sensi-
tivity to change, and the fact that it includes an assess-
ment of cognitive and psychosocial symptoms.
The score range is 0–63 points. The usually accepted
cut-off points for adjusting the intensity/severity are as
follows: No Depression: 0–9 points, mild depression:
10–18 points, moderate depression: 19–29 points and
severe depression: ≥ 30 points [43].
EuroQol quality of life questionnaire
The EQ-5D is a self-report scale allowing a multi-
dimensional description of health and construction of a
digital health profile. It is a standardized measure of
health status, applicable to a wide range of health condi-
tions and treatments which provides a simple descriptive
Table 1 Psychoeducational program
Sessions Objectives
1 First contact with the group
Breathing techniques
2 Behavioral Activation I
Health education and identificated of depressive symptoms
3 Behavioral Activation II
4 How to take care to advance I
- Diet
- Sleep
- Educational about pharmacological treatment
5 Problem solving I
6 Problem solving II
7 Self-esteem and self-image
8 Assertiveness
9 How to take care to advance II
- Pleasant activities, social skills
- Physical exercise
10 Cognitive-behavioral perspective I
11 Cognitive-behavioral perspective II
12 Group farewell
Final evaluation
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This scale was validated in Spain by Xavier Badia in
1999 [45].
Remission
Clinical remission is based upon the BDI, which is a
self-report screening instrument. Remission is defined as
a mean BDI score of ≤11 [46]. On the BDI self-rating
scale, a cut-off of BDI ≤11 emerged for remission with a
sensitivity of 90% and specificity of 64%.
Group treatments
Description of the training
Nurses who lead psychoeducational groups have received
previous training in relation to depression (characteristic
symptoms, diet, sleep, self-esteem, self-image, physical
exercise and pharmacological treatment) and in the
conducted-observation groups by therapists with extensive
experience. They have also been trained in techniques
such as problem solving, relaxation-breathing techniques,
behavioral activation and cognitive restructuring therapy.
The training period was 40 hours.
The GPs received previous training in relation to the
detection and diagnosis of depression in patients, and the
basic principles of group psychoeducational intervention.
Description of the psychoeducational group intervention
The intervention consisted of 12 weekly, 90 minute ses-
sions led by two nurses. A total of 24 nurses collaborated
in the study, two nurses per PCC. During the study
period, twelve groups were formed. Each group consisted
of 8–12 participants.
The research group developed a protocol with a pro-
gram of 12 group sessions in order to homogenize the
study interventions [47].
The description of the objectives of the 12 sessions is
shown in Table 1. The program provided: 1. Health edu-
cation about the illness: symptoms, diet, physical exer-
cise, sleep, pharmacological treatment and adherence to
treatment. 2. Breathing techniques. 3. Problem solving,
Behavioral activation and Cognitive-behavioral perspec-
tive on depression. 4. Self-esteem and self-image. 5.
Pleasant activities, social skills and assertiveness.
To enhance the active role of the patient, each session
was accompanied with homework for the patient. The
participants were free to continue under pharmaco-
logical treatment.
The group interventions were conducted on the PCC
premises. All PCC settings had the space and equipment
necessary to carry out the intervention.
Description of the control group
Members of the control group received usual treatment
(visits with the GP and nurses). There was no pattern ofvisits established; the patients could go to the PCC when
they needed to. The GPs and nurses use their own cri-
teria to attend depressed patients. During the visits,
the patient was asked about their general health status,
adherence to antidepressant treatment (if they had pre-
scribed medication) and the GP and nurses answered
any queries about healthy lifestyle (such as sleep, diet
and exercise). Each visit lasted 10 to 20 minutes. The




The sample size was determined by practical restrictions
and estimation of statistical power. Accepting an alpha
risk of 5% and a beta risk of 20% in a bilateral contrast,
at least 92 subjects were needed in the intervention
group and 92 in the control to detect a difference equal
to or greater than 4.5 units on the BDI scale. It is
assumed that common standard deviation is 10. A loss
rate of up 15% has been estimated.
Statistical analysis
The analysis was carried out on an intent-to-treat basis.
The analyses were based on the data of the 231 partici-
pants who completed some of the evaluations. The intent-
to-treat analysis was carried out as follows; missing values
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ment (the last observation carried forward (LOCF)) to as-
sure no increase. To examine baseline differences in the
sociodemographic and clinical characteristics between
groups, the t-Student test for continuous variables and
Chi-square test for categorical variables were applied.
The effect of the intervention on the outcome variables
was measured by the difference in scores between groups
and the effect size. Standardized effect size (SES) [48] is
calculated as the mean difference between the interven-
tion and the control groups, divided by the standard
deviation (SD) of the control group. The SES is a stan-
dardized measure of the change that allows comparison
between groups, between measures in the same study
and between different studies [49].
The standardized mean response (SMR) was used to
measure the effect size within group comparisons. The
SMR was calculated as the mean change divided by the
SD of the change. Cohen’s d allows classification of ef-
fect size into small (0.2 to 0.5), medium (0.5 to 0.8) and
large (0.8 or over); these criteria can also be applied to
SMR [49,50]. The statistics package IBM SPSS Statistics
v.18 was used [51].Figure 1 Flow chart of participants.To evaluate the evolution of the BDI between groups,
we produced a mixed- effects model, using the monitoring
time (4 times: pretest, 3-month, 6-month and 9-month)
as a random effect, and as a fixed effect: the type of inter-
vention (control versus intervention), age, gender and
the type of PCC. We evaluated the goodness of fit




The flow of participants is shown in Figure 1. Of the 246
assessed in the study, 15 people declined to participate.
Patients characteristics
231 patients were included in the study. Patients were
randomized either to psychoeducational intervention
(n=119) or control group (n=112). These two groups
were similar at baseline in terms of demographic and
clinical characteristics, except with respect to marital
status (p=0.030). Table 2 shows the baseline characteristics
of the total study population and the intervention group.
The typical patient was a woman, Spanish national,
Table 2 Baseline characteristics of the total study population and intervention group. Values are numbers (percentages)
Variable Category Variable Category General n (%) Intervention n (%) Control n (%)
Gender Women 206(89.2) 108 (90.8) 98 (87.5)
Age Mean (SD) 53.38(12.63) 52.29(11.77) 54.54 (13.44)
Nationality Spanish 215 (93.1) 111 (93.3) 104 (92.9)
Single 33 (14.3) 20(16.8) 13 (11.7)
Marital status * Married/cohabitant 119 (51.7) 65 (54.6) 54 (48.2)
Divorced/separed 41 (17.8) 23 (19.3) 18 (16.2)
Widow/widowed 37 (16.1) 11 (9.2) 26 (23.4)
Not completed primary education 27 (11.8) 14 (11.8) 13 (11.9)
Educational level Completed primary education 88 (38.6) 42 (35.3) 46 (42.2)
Secondary education 69 (30.3) 39 (32.8) 30 (27.5)
University 44 (19.3) 25 (20.8) 20 (18.3)
Nº Childrens 0 Children 63 (27.3) 31 (26.1) 32 (28.6)
1-2 Children 113 (48.9) 61 (51.3) 52 (46.4)
>=3Childrens 55 (23.8) 27 (22.7) 28 (25)
Self- Employed 97 (42.4) 56 (47.1) 41 (37.3)
Disability or permanent disability 20 (8.7) 9 (7.6) 11 (10)
Employment status Unemployed 32 (14) 18 (15.1) 14 (12.7)
Works at home 36 (15.7) 19 (16) 17 (15.5)
Retired 44 (19.2) 17 (14.3) 27 (24.5)
Alone 41 (17.9) 17 (14.2) 24 (21.8)
With childrens 32 (14) 17 (14.3) 15 (13.6)
With his/her partner 52 (22.7) 28 (23.5) 24 (21.8)
With his/her partner and children 66 (28.8) 36 (30.3) 30 (27.3)
Core coexistence With parents 13 (5.7) 8 (6.7) 5 (4.5)
With others family 11 (4.8) 8 (6.7) 3 (2.7)
With other people 8 (3.5) 3 (2.5) 5 (4.5)
Others 6 (2.6) 2 (1.7) 4 (3.6)
Permanent contract 74 (34.7) 43 (37.7) 31 (31.3)
Employment Economic status Temporary contract 8 (3.8) 3 (2.6) 5 (5.1)
Self-employment 14 (6.6) 7 (6.1) 7 (7.1)
Work without contract 12 (5.6) 9 (7.9) 3 (3)
Not work, but have a salary 77 (36.2) 39 (34.2) 38 (38.4)
Not work, not salary 28 (13.1) 13 (11.4) 15 (15.2)
Stressful event Yes 138 (63) 73 (65.2) 65 (60.7)
Medication: Antidepressant Yes 129 (55.8) 71 (55) 58 (45)
No 102 (44.2) 48 (47.1) 54 (52.9)
SSRI 105 (45.7) 60 (50.4) 45 (40.5)
Tricyclic 6 (2.6) 4 (1.7) 2 (0.9)
Dual 20 (8.7) 9 (7.6) 11 (9.9)
Medication: Anxiolytics Yes 125 (54.3) 67 (56.8) 58 (51.8)
Hypnotics Yes 11 (4.8) 7 (5.9) 4 (3.6)
Alternative treatment Yes 51 (22.1) 28 (23.5) 23 (20.5)
Medication: blood pressure Yes 70 (30.3) 32 (26.9) 38 (33.9)
Abbreviations: SD: standard deviation; SSRI: serotonin-norepinephrine reuptake inhibitors.
* P value significant (p=0.030).
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mary education and self-employed. She had one/two
children and referred to a stressful event in the previous
months.
Those allocated to the psychoeducational group
received a mean of 8.68 (SD 3.64; range 0–12) sessions.
Adherence to psychoeducational intervention was rea-
sonably good, with only 2 of 119 (1.68%) patients not
attending any sessions and 88 (73%) receiving at least
eight or more sessions.
The sessions received by the intervention group
were: 12 sessions (n=38); 11 sessions (n= 15); 10 ses-
sions (n= 23); 9 sessions (n= 6); 8 sessions (n= 6); 7
sessions (n= 3); 6 sessions (n= 3); 5 sessions (n= 2); 4 ses-
sions (n= 1); 3 sessions (n=1); 2 sessions (n= 5); 1 session
(n= 14) and 0 sessions (n= 2).
Attrition and dropout
Sixty-one patients were not evaluated at post-treatment
(did not respond to the BDI questionnaire), 26 from the
IG and 35 from the CG. At 6 month follow up, 42 from
the IG and 48 from the CG, and at 9 month follow up,
37 from the IG and 42 from the CG.
Of these, 61 patients were not evaluated at post-
treatment, 54 of them were drop-outs (drop-outs =
patients who were not evaluated at post-treatment and
follow-up assessments at 6 and 9 months). Therefore,
the overall drop-out rate was 23%. The drop-out rate was
19.3% (n=23) in the intervention group and 24.1% (n=27)
in the control group. Drop-outs from the experimental
condition did not differ statistically from those in the
control group at follow-up assessment. The reasons for
drop-out were: not contactable by telephone and did
not attend the interview with the nurse (n=42), notTable 3 Remission of depression in the overall, mild and mod
Sample Months Control n (%) Intervention n (
(n= 112) (n= 119)
Overall 3 21 (18.75) 41 (34.45)
6 30 (26.79) 48 (40.34)
9 30 (26.79) 48 (40.34)
(n= 37) (n= 48)
3 15 (31.30) 21 (56.80)
Mild 6 20 (41.70) 22 (59.50)
9 18 (37.50) 24 (64.90)
(n= 82) (n= 64)
3 6 (9.40) 20 (24.40)
Moderate 6 10 (15.60) 26 (31.70)
9 12 (18.80) 24 (29.30)
Abbreviations: IC interval coefficient.
* Difference was calculated between intervention and control group.interested in the study (n=1), change of address (n=3),
referred to a secondary mental health service (n=2)
and other unspecified reasons (n=6).
We analysed the 231 patients included in the study, as
the analysis was carried out on an intent-to-treat basis.
Intervention effectiveness: remission
The proportion of patients achieving remission status
(BDI≤11 score) was examined using the Riedel remission
criteria for major depression [46].
Post-test results showed that more participants in the
intervention group (34.5%) had scored in the non-
symptomatic BDI range (BDI≤11 score) than participants
in the control group (18.8%); the 15.7% difference was
statistically significant (p=0.003, 95% CI 4.5 to 26.9).
After 6 and 9 month follow-up the results were similar;
the proportion was 40.3% in the intervention group and
26.8% in the control group and the 13.5% difference was
statistically significant (p=0.014, 95% CI 1.5 to 25.6).
Table 3 shows the proportion of patients remitting
through treatment in the overall, mild and moderate
sample. The number needed to treat (NNT) is about 6.4
at short-term, and 7.4 for the long-term (after 9 months);
i.e. reducing BDI below 11.
As we were interested in analyzing what kind of popu-
lation can benefit most from receiving the intervention,
participants were categorized into mild (BDI ≤18) and
moderate initial depressive symptomatology (BDI ≥19),
based on the pretest BDI sample median. Of the total
sample of 231 people, 86 had mild symptoms and 146
moderate symptoms at baseline.
In patients with mild depression (pretest BDI), results
showed that the remission was statistically significant at
post-test and at 6 and 9 month follow-up.erate sample
%) % difference at each
follow-up *
(IC95%) P-value
15.70 (4.5 to 26.9) 0.003
13.55 (1.5 to 25.6) 0.014
13.55 (1.5 to 25.6) 0.014
25.50 (5.01 to 46) 0.009
17.80 (−3.3 to 39) 0.051
27.40 (6.7 to 48) 0.006
15.00 (2.7 to 27.2) 0.007
16.10 (2.2 to 29.9) 0.011
10.50 (− 3.4 to 24.5) 0.068
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non-symptomatic range of the BDI was 56.8% in the
intervention group and 31.3% in the control group, the
25.5% difference was statistically significant (p=0.009,
95% CI 5.01 to 46). At 6 month follow-up, the propor-
tion was 59.5% in the intervention group and 41.7% in
the control group, but the 17.8% difference was not
statistically significant (p=0.051, 95% CI −3.3 to 39).
After 9 months the proportion was 64.9% in the inter-
vention group and 37.5% in the control group; the
27.4% difference was statistically significant (p= 0.006,
95% CI 6.7 to 48) (Table 3).
In patients with moderate depression (pretest BDI),
results showed that the remission was statistically signifi-
cant at post-test and 6 month follow-up. At post-test,
the proportion was 24.4% in the intervention group and
9.4% in the control group; the 15% difference was statis-
tically significant (p=0.007, 95% CI 2.7 to 27.2) and at
6-month follow-up it was 31.7% in the intervention
group and 15.6% in the control group (16.1% difference;
p= 0.011, 95% IC 2.2 to 29.9) but after 9 months, results
were not statistically significant (10.5% difference;
p=0.068, 95% CI −3.4 to 24.5) (Table 3).Depressive symptomatology
Depressive symptoms were assessed through the Beck
Depression Inventory (BDI). The difference between
treatments at 3 months (psychoeducation intervention
minus control) was estimated to be – 2.12 (95% CI −4.03
to −0.214) which was significant (P=0.029). The negative
sign indicates that participants in the psychoeducation
intervention had fewer depressive symptoms than those
in the control group. The results at 6 and 9 months were
not significant. Table 4 shows the changes in the BDI
within and between the intervention and usual care
group with missing data replaced using last value carried
forward.
A 2 (condition: intervention, control) x 4 (time: pre-
test, 3-month follow-up (post-test), 6-month follow-up,
and 9-month follow-up) mixed-effects linear regression
model showed a significant condition x time inter-
action. The results show that the evolution of the BDI
over time between groups was significant, (p value
non- linear trend =0.007). The effect size of this con-
trast is smaller in the short (post-test) and long term
(9 month follow up): d’=.29 and d’=.16, respectively.
Figure 2 shows the evolution of the BDI over time in
the overall sample.
If, in this sample, we analysed the intervention and
control group separately, the effect size within the inter-
vention group (SRM) was moderate over time (d’= .77
post- intervention and d’=.72 at 9 month follow up) and
the effect size within the control group was small overtime (d’= .36 post- intervention and d’=.44 at 9 month
follow up).
In patients with mild depression (pretest BDI), the dif-
ference between treatments at 3 months (psychoeduca-
tion intervention minus control) was estimated to be
−2.85 (95% CI −5.16 to −0.542) which was significant
(p=0.016). The results at 6 and 9 months were signifi-
cant (p=0.052 and p=0.048, respectively) (Table 4). The
results show that the BDI was significantly affected by
the time, p<.001, indicating that self-reported depressive
symptomatology declined significantly during the course
of treatment although regardless of which treatment was
received, it was significantly affected by the type of inter-
vention, (p value no-linear trend =0.045). The effect size
of this contrast is moderate at short-term (d’= .51) and
at long-term (d’= .44).
If, in this sample, we analysed the intervention and
control group separately, the effect size within interven-
tion group was moderate over time (d’= .71 post-
intervention and d’=.70 at 9 month follow up) and the
effect size within control group was small over time
(d’= .17 post- intervention and d’=.30 at 9 month follow
up).
In patients with moderate depression (pretest BDI),
the difference between treatments at 3 months (psycho-
education intervention minus control) was estimated to
be −3.08 (95% CI −5.41 to −0.76) which was significant
(p=0.001). The results at 6 and 9 months were not sig-
nificant (p=0.58 and p=0.17, respectively) (Table 4). The
results show that the BDI was significantly affected over
time, p<.001 and according to type of intervention,
(p value non-linear trend =0.022). The effect size of this
contrast is smaller in the short-term (d’=.47) and the
long-term (d’= .24). Figure 3 shows the evolution of the
BDI over time in the mild and moderate sample.
If, in this sample, we analysed the intervention and
control group separately, the effect size within interven-
tion group was large (d’= .83) post-intervention and
moderate at 9 month follow up (d’=.74), and the effect
size within control group was small (d’= .49) post-
intervention and moderate (d’=.54) at 9 month follow up.
Quality of life
Quality of life was assessed using the EQ-5D question-
naire. Table 5 shows the changes in the EQ-5D within
and between the intervention and usual care group with
missing data replaced using last value carried forward.
The difference between treatments at 3 months (psy-
choeducation intervention minus control) was estimated
to be 4.19 (95% CI −0.31 to 8.66) which was a trend to-
wards significance (p=0.067). The positive sign indicates
that participants in the psychoeducational intervention
improved their quality of life more than the control group.
The results at 6 and 9 months were not significant, and
Table 4 Overall, mild and moderate sample. Changes in the BDI within and between the intervention and usual care group with missing data replaced using
last value carried forward
Usual care group (n=112) Intervention group (n=119) Difference (95% CI) between groups
(intervention group -usual care group)**
Sample Months mean (SD) Difference* (95% CI) SRM# mean (SD) Difference*(95% CI) SRM# Difference P-value SES$
Pre-intervention 19.62 (5.79) 20.90 (5.68)
3 (Post-intervention) 17.54 (7.18) 2.07 (1.0 to 3.1) 0.36 15.42 (7.53) 5.47(4.19 to 6.76) 0.77 −2.12 (−4.03 to −0.214) 0.029 0.29
Overal 6 16.51 (7.60) 3.1 (1.7 to 4.4) 0.43 15.37 (8.74) 5.52 (3.9 to 7.08) 0.64 −1.13 (−3.27 to 0.992) 0.293 0.15
9 16.35 (7.84) 3.26 (1.9 to 4.6) 0.44 15.09 (8.62) 5.8 (4.3 to 7.26) 0.72 −1.25 (−3.39 to 0.886) 0.249 0.16
Usual care group (n=48) Intervention group(n=37)
Pre-intervention 14.08 (2.72) 13.81 (2.50)
Mild 3 (Post-intervention) 13.23 (5.57) 0.85 (−0.56 to 2.2) 0.17 10.38 (4.94) 3.43(1.81 to 5.04) 0.71 −2.85 (−5.16 to −0.542) 0.016 0.51
6 13.15 (6.02) 0.93 (−0.78 to 2.65) 0.15 10.65 (5.46) 3.16 (1.15 to 5.16) 0.52 −2.50 (−5.015 to 0.200) 0.052 0.42
9 12.27 (5.78) 1.81 (0.06 to 3.56) 0.30 9.70 (5.93) 4.11 (2.17 to 6.04) 0.70 −2.57 (−5.114 to −0.220) 0.048 0.44
Usual care group (n=64) Intervention group(n=82)
Pre-intervention 23.77 (3.6) 24.10 (3.31)
Moderate 3 (Post-intervention) 20.8 (6.6) 2.99 (1.45 to 4.51) 0.49 17.7 (7.4) 6.40(4.71 to 8.09) 0.83 −3.08 (−5.41 to −0.762) 0.010 0.47
6 19.00 (7.7) 4.74 (2.86 to 6.60) 0.63 17.5 (9.1) 6.60 (4.54 to 8.65) 0.70 −1.53 (−4.35 to 1.28) 0.285 0.20
9 19.4 (7.8) 4.36 (2.35 to 6.36) 0.54 17.50 (8.6) 6.58 (4.63 to 8.50) 0.74 −1.89 (−4.60 to 0.840) 0.174 0.24
Abbreviations: SD standard deviation; CI confidence interval.
* Differences were calculated between baseline measurement and follow-up measurement.
Positive differences indicate improvement; a negative one denotes some worsening on clinical measures.
# SRM: Standardized response mean. Calculated as the mean change in score divided by the standard deviation of the change in score.
$ SES: Standardized effect size was computed as the mean difference between intervention and control group divided by the standard deviation of the control measurement.
A positive SRM or SES denotes improvement; a negative one denotes some worsening on clinical measures.
** Difference was calculated between intervention group and control group.
Negative differences indicate improvement in the intervention group; Positive differences denote worsening in the intervention group.


















Figure 2 Evolution of the BDI over time in the overall sample.
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http://www.biomedcentral.com/1471-244X/12/230the difference between treatments descends at 9 months
to 1.54 (95% CI −3.43 to 6.51). If, in this sample, we ana-
lyzed the intervention and control group separately, the
post-intervention results show that the intervention group
had an improvement in the EQ-5D of 8.97 points (95%
CI 12.20 to 5.72; p<0.001) and was statistically significant.
In the control group, the improvement was 2.29 points
(95% CI 4.6 to −0.01; p=0.052), which was a trend towards
significance (Table 5).
Separate sample analyses in patients with mild depres-
sion showed the difference between treatments at
3 months (psychoeducation intervention minus control)
was estimated to be 4.99 (95% CI −2.11 to 12.09) whichFigure 3 Evolution of the BDI over time in the mild and moderate samwas not significant (p=0.166). The results at 6 and
9 months were not significant, but the difference be-
tween treatments at 9 months was estimated to be 5.26
(95% CI −2.39 to 12.92), thus the improvement in qual-
ity of life was maintained over time. If, in this sample,
we analyzed the intervention and control group separ-
ately, the post-intervention results show that the inter-
vention group had an improvement in the EQ-5D of
7.89 points (95% CI 13.84 to 1.94; p=0.011), this was
statistically significant and the improvement was main-
tained over time. The control group had an improve-
ment of 2.79 points (95% CI 6.17 to 0.59; p=0.103),
which was not significant.ple.
Table 5 Overall, mild and moderate sample. Changes in the EQ-5D within and between the intervention and usual care group with missing data replaced
using last value carried forward
Usual care group (n=112) Intervention group (n=119) Difference (95% CI) between groups
(intervention group -usual care group)**
Sample Months mean (SD) Difference*(95% CI) SRM# mean (SD) Difference*(95% CI) SRM# Difference P-value SES$
Pre-intervention 53.25 (17.63) 50.76 (18.73)
3 (Post-intervention) 55.54 (16.36) 2.29 (4.6 to −0.01) 0.19 59.7 (18.1) 8.97(12.20 to 5.72) 0.50 4.19 (−0.31 to 8.66) 0.067 0.26
Overall 6 57.05 (16.97) 3.80 (6.98 to 0.61) 0.22 57.9 (20.7) 7.09 (10.78 to 3.39) 0.34 0.81 (−4.12 to 5.73) 0.748 0.05
9 57.69 (17.35) 4.44 (8.0 to 0.87) 0.23 59.2 (20.8) 8.46 (11.99 to 4.93) 0.43 1.54 (−3.43 to 6.51) 0.543 0.09
Usual care group (n=48) Intervention group (n=37)
Pre-intervention 57.92 (18.10) 57.81 (17.58)
Mild 3 (Post-intervention) 60.71 (16.00) 2.79 (6.17 to −0.59) 0.24 65.7 (16.7) 7.89(13.84 to 1.94) 0.44 4.99 (−2.11 to 12.09) 0.166 0.31
6 60.90 (16.49) 2.98 (7.71 to −1.75) 0.18 64 (18.1) 6.14 (12.73 to −0.47) 0.31 3.05 (−4.43 to 10.53) 0.420 0.18
9 62.52 (15.02) 4.60(9.75 to −0.54) 0.25 67.8 (20.5) 9.97 (16.82 to 3.11) 0.48 5.26 (−2.39 to 12.92) 0.175 0.35
Usual care group (n=64) Intervention group (n=82)
Pre-intervention 49.75 (16.56) 47.59 (18.46)
3 (Post-intervention) 51.67 (15.67) 1.92 (5.15 to −1.31) 0.15 57.04 (18.08) 9.45(13.39 to 5.50) 0.52 5.36 (−0.263 to 10.99) 0.062 0.34
Moderate 6 54.17 (16.88) 4.42 (8.82 to 0.02) 0.25 55.11 (21.35) 7.52 (12.07 to 2.97) 0.36 0.93 (−5.49 to 7.37) 0.774 0.06
9 54.06 (18.20) 4.31 (89.33 to −0.70) 0.21 55.37 (19.83) 7.78 (11.95 to 3.60) 0.40 1.30 (−5.00 to 7.61) 0.684 0.07
Abbreviations: SD standard deviation. CI confidence interval.
* Differences were calculated between follow-up measurement and baseline measurement.
Positive differences indicate improvement; a negative one denotes some worsening on clinical measures.
# SRM: Standardized response mean. Calculated as the mean change in score divided by the standard deviation of the change in score.
$ SES: Standardized effect size was computed as the mean difference between intervention and control group divided by the standard deviation of the control measurement.
A positive SRM denotes improvement; a negative one denotes some worsening on clinical measures.
** Difference was calculated between intervention group and control group.
Positive differences indicate improvement in the intervention group. Negative differences denote worsening in the intervention group.
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http://www.biomedcentral.com/1471-244X/12/230In patients with moderate depression, the difference
between treatments at 3 months (psychoeducation inter-
vention minus control) was estimated to be 5.36 (95%
CI −0.26 to 10.99) which was not significant (p=0.062).
The results at 6 and 9 months were not significant. If,
in this sample, we analyzed the intervention and control
group separately, the post-intervention results show that
the intervention group had an improvement in the
EQ-5D of 9.45 points (95% CI 13.39 to 5.50; p<0.001).
This was statistically significant, and the Control Group
showed no significant improvements; -1.92 points (95%
CI 5.15 to 1.31; p=0.239).Discussion
We found a relationship between the psychoeducational
group intervention and remission of depressive symp-
toms. More patients from the IG had remission of their
depressive symptoms at short and long term compare
with the control group. The psychoeducational group
intervention proved to be effective in the short term,
showing a reduction in the BDI score of 5 points and
this symptomatic improvement in the BDI continued to
follow up at 9 months. In contrast, the control group
needed 9 months to achieve a 3 point improvement in
the BDI. We could say that it is an effective intervention
in the short term, although the effect size is small.
When analyzing what kind of population can benefit
most from receiving the group intervention; mild or
moderate depression participants, we found that patients
with mild symptoms obtained a higher rate of symptom
remission in the short and long term and symptomatic
improvement in the BDI remained over the long term,
as distinct from the moderate depression group, where
the improvement was only significant post-intervention
(short term).Comparison with other studies
Psychoeducation has proved effective as psychotherapy
for depressive-symptom management in the Primary
Care setting [24,26-28,30,52,53]. However, there is a need
to clarify both the magnitude of the effect (from 0.21 to
0.80) of this intervention and the associated factors that
influence the measurement of efficacy. Some factors to
take into account have been described: the type of psy-
choeducational intervention used [24,26,27,29,30,53], the
clinical rating scale [24,26,27,30,53], intensity of clinical
depressive symptoms at the beginning [26,28,54], and the
duration of the therapeutic effect of the intervention
[24,26-28,30,52].
One of the greatest difficulties in reviewing studies on
the effectiveness of group psychoeducation in depression
in primary care is that there is no consensus on the defin-
ition of psychoeducation. The studies which have used theterm "psychoeducation" to define the type of psychological
therapy have defined it as an applied educational-
behavioral intervention [29], or interventions with behav-
ioral components (behavior change, pleasant activities),
cognition (cognitive restructuring, counseling), education
(direct instruction, lectures) and competence (broad
skill training) [26,55]. Thus, we find interventions of vari-
ous orientations that share a high didactic and psycho-
educational group structure. This would include CBT
orientation interventions with a psychoeducational group
format structure [53], specific psychoeducational inter-
ventions to improve adherence to drug treatment [29],
and multicomponent interventions (stepped care) struc-
tured in a psychoeducational group format [30]; or
the CWD course of cognitive-behavioral orientation
[14,24,26,27,31]. Most studies [24,27,28,30,52,53] that
have used a psychoeducational intervention also included
homework for the patient.
In our study, we developed a psychoeducational group
intervention protocol that included material from the
12 sessions [47], a CD with the material from each
session and homework for the patient; so reaffirming the
concept of psychoeducation in our intervention.
There are few randomized studies of group psycho-
education based on this approach of providing education
about the disorder and healthy lifestyle behaviors;
aspects that have been shown to help in the recovery of
these patients [15,39,56].
Most studies that have evaluated the effectiveness of
psychoeducation have used the Beck Depression Inven-
tory (BDI) [24,26,27,52,53] as a clinical assessment scale,
which, unlike the Hamilton Rating Scale for Depression
(HRSD) [30], includes the psychological and psycho-
social aspects, emphasizing the cognitive component of
depression which is a very important issue in primary
care.
The effectiveness of psychoeducation in the short term
(post-intervention or 3 months) has already been demon-
strated [26,30,52] and there are no discrepancies between
studies. However, with respect to the duration of the
therapeutic effect of psychoeducation at 6 and 12 month
follow-up, results are controversial. The study by Allart-
van Dam [28] evaluated the long-term preventive effects
of an effective CWD course in the same sample of
patients as in the earlier study [26] with a significant
effect at 6 and 12 month follow-up (p=0.003 and
p=0.03 respectively) but only in the participants with
low initial symptomatology (BDI between 10 and 25).
The study by Dalgard [27] evaluated the effect of a modi-
fied CWD course on unipolar depression at 6 and
12 month follow-up. Results showed that there was a
significant improvement in symptoms (p=0.009) and
the effect size at 6 month follow-up was small (d’=.47)
but at 12 month follow-up, the BDI in the intervention
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study by Dowrick [26] evaluated the psychoeducation
group for depressed adults and the results show us that
the psychoeducation intervention reduced the severity
and duration of depressive disorder after 6 months, but
not at 12 months. In the study by Brown [52], patients
significantly improved their BDI at 6 and 12 month
follow-up, and in the study by Araya [30], significant
improvements of 9 points between groups (p <0.0001)
were maintained at 6 month follow-up.
Our results shows a significant improvement in symp-
toms post-intervention (p = 0.029; d’=.29) although the
effect size is small but this improvement is not main-
tained at 9 month follow up (p = 0.24; d’=.16).
If we focus on the severity of initial clinical depressive
symptoms, most studies included a sample of patients
with an average BDI of 22. When we tried to identify the
subgroup of patients which most benefits from this inter-
vention, we divided the population according to their
initial BDI: "mild" (BDI ≤ 18) or "moderate" (BDI ≥ 19).
It was observed that patients with mild depressive symp-
toms have significantly improved symptoms in the short
and long term (p = 0.001 and p = 0.048, respectively)
with a moderate and small effect size (d’=.51 and d’=.44,
respectively).
Our results coincide with those found in a review [54]
where it is shown that psychological treatments for
minor depression, including psychoeducation, are effect-
ive in the short-term (d’ = .42). However, the long-term
improvement was not significant. Another study [26,28]
concluded that patients with mild symptoms had low
levels of depressive symptoms during the follow-up
period, and at one year this population had depression
scores that indicated an absence or very low level of
symptoms.
However, when analyzing the sample of patients with
moderate symptoms, our results show significant im-
provement in symptoms only in the short-term with a
small effect size (d’ = 0.47).
In conclusion, we could say that the effectiveness of
psychoeducation would be short-term (post-intervention)
in the population with more severe symptomatology
while, in patients with mild symptoms, it would be effect-
ive at both short and long term (follow-up at 6 and
9 months).
One of the most important aspects of our study is to
evaluate the effectiveness of the intervention based on
the remission of symptoms.
In relation to the remission of depressive symptoms
(BDI ≤ 11) [46], our results show that 35% of the inter-
vention group (IG) versus 19% in the control group
(CG) had depressive symptoms post-intervention, and
this 16% difference between groups was significant
(p = 0.003). Follow-up at 6 and 9 months showed asignificant difference of 14% (p = 0.01), with a 40%
improvement in the IG versus 27% in the CG. These
data are consistent with those found in one study [26]
which showed that 52.5% of the intervention group
did not present depressive symptoms (BDI <10) (Beck,
1988) post-intervention compared with the control
group; 31.7%, with a significant difference of 20.8%
(p = 0.04) between groups.
When analyzing the sample of patients with mild
symptoms (initial BDI ≤ 18), we observed that 57%
of the intervention group showed an absence of de-
pressive symptoms versus 31% in the control group
post-intervention, with a significant difference between
groups of 25% (p = 0.009).
At 6 month follow-up, 59% of the intervention group
improved versus 42% of the control group; a difference
of 18%, and at 9 month follow-up, 65% improved in
the intervention group versus 38% in the control group,
with a 27% significant difference between groups
(p = 0.006). These results support the effectiveness of
this intervention in this subgroup of patients.
When we talk about the remission of symptoms in
terms of number needed to treat (NNT), we observed
that our NNT of 6.4 post-intervention and 7.4 at
9 month follow-up are supported by those obtained in
the study by Dalgard [27] with a smaller sample of
patients (n = 155) which was 6 at 6-month follow-up,
and the Dowrick ODIN study [16] (n = 452) which was
7 at 6 months, supporting the effectiveness of the inter-
vention. Another variable analyzed was quality of life
and whether this could be associated with an improve-
ment in depressive symptoms. At first, it was seen that
the patients with mild symptoms have better quality of
life compared with those with the most severe symp-
toms, although it has been observed at baseline that
milder symptom patients already had better quality of
life compared with those with the most severe.
Our results show that psychological intervention
improves quality of life for both groups in the short-term,
but only the patients with mild symptoms maintain this
long-term improvement. No significant differences were
found between the intervention group and the control
group but this may be due to methodological issues
related to the questionnaire used, EQ-5D, which has no
cut-off points.
According to the results, this intervention is effective
in both the short and long term with high rates of remis-
sion in patients with mild depressive symptoms.
We should mention the minor depression has a
prevalence of 5–16% in primary care patients [57]
and is an important risk factor for major depression,
which develops in 10–25% of patients with subthres-
hold depression within 1–3 years [58]. It is also associated
with psychological suffering, significant decrements in
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siderable impact on quality of life [57].Strengths and limitations of this study
Our trial has a number of strengths: firstly, it is the first
study to assess the effectiveness of this psychoeduca-
tional group intervention which includes health educa-
tion about the disorder, healthy behaviors, social skills
and cognitive-behavioral techniques. Secondly, deter-
mining the target population; in this case patients with
mild depression. Third, the study was conducted in
Spain, specifically in Catalonia, and this is the first mul-
ticenter randomized study that assesses the effectiveness
of a psychoeducational intervention in this country.
Fourth, the sample population was representative of all
Barcelona. The PCC participants were located in various
areas of Barcelona, with different socio-demographic and
economic resources. And finally, highlighting the role of
the nurses who led the psycho-educational groups.
Despite the positive findings, potential biases need to
be considered when evaluating the study. Some of the
limitations of the study could be as follows: firstly, we
performed a randomization of patients, but there is no
double-blind, the patient knows who belongs to the
intervention or control group, as do the nurses and doc-
tors in the PCC. It was difficult for researchers to remain
masked to group allocation. However, participants com-
pleted self-rating assessments of mood and quality of life.
Therefore, that lack of blindness should not have affected
our primary outcome to any great extent.
Secondly, the study employed only a two-outcome
measure, BDI and EQ-5D, as we wanted the study to be
as close as possible to the usual practice of the Primary
Care Centers. It is a naturalistic study. Thirdly, the remis-
sion of depression was assessed by a screening question-
naire (BDI) rather than a diagnostic interview. Fourth,
the overall drop-out was 23%, when we estimated a
loss rate up 15%. This loss rate would affect to estimate
the real evolution of the BDI a long-term. There wasn’t
difference between groups in the loss rate. These losses
are consistent with those found in other studies; between
25% and 37% [14,18]. Finally, further studies are required
to confirm these results.Conclusions
Our results show that this psychoeducational interven-
tion is more effective in patients with mild symptoms,
since they have higher remission rate of symptoms at
short and long term. Moreover, this improvement is
associated with a better quality of life. The data do not
demonstrate that the intervention is effective at long
term in patients with moderate symptoms.Abbreviations
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